UBS Investor Sentiment
Momentum stalled
Key findings
Key findings
Vaccine challenges | Sentiment falls amid slow rollouts
Inflation worries | More than half expect an increase in the next 3 years
Excess of cash | Investors consider new alternatives
ECONOMY
ECONOMY
Investors see vaccine rollouts being far from successful...
...causing short-term economic outlook to decrease
(over the next 12 months, in %)
Top sources of optimism and concern
Optimism
Concern
Market outlook
Market outlook
Most investors see the US as very attractive for investing in the short-term
Investments
Investments
Investors see inflation growth as inevitable within the next 3 years
Confidence in own businesses strongly led by vaccine development
Sources of optimism
Business owners realize working setups have changed and do not foresee “going back”
Business owners' investment priorities are partially linked to IT matters
About the survey
About the survey
UBS surveyed 150 investors and 50 business owners in Brazil with at least $1M in investable assets (for investors) or at least $1M in annual revenue and at least one
employee other than themselves (for business owners), from March 30 – April 18, 2021. For the 4Q20 results, UBS surveyed 150 investors and 50 business owners
in Brazil, from December 29, 2020 – January 11, 2021.